Friday, Dec. 11, 2015, 75 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $334.02 to $1,962,660.00.

Highlighted Stocks Traded by Insiders:

Axis Capital Holdings (AXS) - FREE Research Report

Gieryn Richard T JR, who is General Counsel and Secretary at Axis Capital Holdings, sold 17,700 shares at $56.60 on Dec. 11, 2015. Following this transaction, the General Counsel and Secretary owned 56,094 shares meaning that the stake was reduced by 23.99% with the 17,700-share transaction.

The shares most recently traded at $56.21, down $0.39, or 0.7% since the insider transaction. Historical insider transactions for Axis Capital Holdings go as follows:

  • 4-Week # shares sold: 1,725
  • 12-Week # shares bought: 176,000
  • 12-Week # shares sold: 1,725
  • 24-Week # shares bought: 176,000
  • 24-Week # shares sold: 1,725

The average volume for Axis Capital Holdings has been 447,500 shares per day over the past 30 days. Axis Capital Holdings has a market cap of $5.5 billion and is part of the financial sector and insurance industry. Shares are up 10.14% year-to-date as of the close of trading on Friday.

AXIS Capital Holdings Limited, together with its subsidiaries, provides specialty lines insurance and treaty reinsurance products worldwide. The company operates through Insurance and Reinsurance segments. The stock currently has a dividend yield of 2.47%. The company has a P/E ratio of 9.0. Currently, there are 4 analysts who rate Axis Capital Holdings a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AXS - FREE

TheStreet Quant Ratings rates Axis Capital Holdings as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Axis Capital Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

National Health Investors (NHI) - FREE Research Report

Mccabe Robert A Jr, who is Director at National Health Investors, bought 35 shares at $59.10 on Dec. 11, 2015. Following this transaction, the Director owned 8,130 shares meaning that the stake was boosted by 0.43% with the 35-share transaction.

The shares most recently traded at $59.64, up $0.54, or 0.91% since the insider transaction. Historical insider transactions for National Health Investors go as follows:

  • 4-Week # shares bought: 1,130
  • 4-Week # shares sold: 5,950
  • 12-Week # shares bought: 1,130
  • 12-Week # shares sold: 5,950
  • 24-Week # shares bought: 8,640
  • 24-Week # shares sold: 5,950

The average volume for National Health Investors has been 238,900 shares per day over the past 30 days. National Health Investors has a market cap of $2.2 billion and is part of the financial sector and real estate industry. Shares are down 14.52% year-to-date as of the close of trading on Friday.

National Health Investors Inc. is a real estate investment trust. It invests in the real estate markets of United States. The firm invests in the health care properties primarily in the long-term care and senior housing industries. The stock currently has a dividend yield of 5.73%. The company has a P/E ratio of 17.9. Currently, there is 1 analyst who rates National Health Investors a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NHI - FREE

TheStreet Quant Ratings rates National Health Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, compelling growth in net income, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full National Health Investors Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Guidance Software (GUID) - FREE Research Report

Ackerman Jay R, who is Chief Revenue Officer at Guidance Software, sold 7,131 shares at $5.73 on Dec. 11, 2015. Following this transaction, the Chief Revenue Officer owned 72,869 shares meaning that the stake was reduced by 8.91% with the 7,131-share transaction.

The shares most recently traded at $5.44, down $0.29, or 5.33% since the insider transaction. Historical insider transactions for Guidance Software go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 13,120
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 13,120
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 13,120

The average volume for Guidance Software has been 68,200 shares per day over the past 30 days. Guidance Software has a market cap of $169.6 million and is part of the technology sector and computer software & services industry. Shares are down 25.38% year-to-date as of the close of trading on Friday.

Guidance Software, Inc. provides digital investigative solutions in the United States, Europe, Asia, and internationally. Currently, there are 3 analysts who rate Guidance Software a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GUID - FREE

TheStreet Quant Ratings rates Guidance Software as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity and generally disappointing historical performance in the stock itself. Get the full Guidance Software Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.